J. Ke

High-performance liquid chromatography of lidocaine and nine of its metabolites in human plasma and urine.

M. Gray, D. Wyse, R. T. Coutts, 1987, Journal of chromatography.

Physiologically based pharmacokinetic modeling for assessing the clinical drug-drug interaction of alisporivir.

T. Heimbach, Imad Hanna, G. Sunkara, 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

A sensitive and high-throughput LC-MS/MS method for the quantification of pegylated-interferon-alpha2a in human serum using monolithic C18 solid phase extraction for enrichment.

F. Tse, M. Bryant, Ziping Yang, 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Safety, pharmacokinetics, and antiviral activity of the cyclophilin inhibitor NIM811 alone or in combination with pegylated interferon in HCV-infected patients receiving 14 days of therapy.

J. Praestgaard, T. Marbury, E. Lawitz, 2011, Antiviral research.

Population Pharmacokinetics of Telbivudine and Determination of Dose Adjustment for Patients With Renal Impairment

D. Mayers, W. Sallas, J. Ke, 2009, Journal of clinical pharmacology.

Absence of Effect of Telbivudine on Cardiac Repolarization: Results of a Thorough QT/QTc Study in Healthy Participants

D. Mayers, F. Poordad, Limin Xu, 2009, Journal of clinical pharmacology.

Simultaneous determination of ribavirin and ribavirin base in monkey plasma by high performance liquid chromatography with tandem mass spectrometry.

F. Tse, Wei Zhou, T. Ray, 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Phase I, Open-Label, Single-Dose Study To Evaluate the Pharmacokinetics and Safety of Telbivudine in Children and Adolescents with Chronic Hepatitis B

J. Praestgaard, D. Stein, J. Ke, 2013, Antimicrobial Agents and Chemotherapy.

622 SAFETY, AND TOLERABILITY OF NIM811, A NOVEL CYCLOPHILIN INHIBITOR FOR HCV, FOLLOWING SINGLE AND MULTIPLE ASCENDING DOSES IN HEALTHY VOLUNTEERS AND HCV-INFECTED PATIENTS

J. Praestgaard, T. Marbury, R. Rozier, 2009 .

1045 SAFETY AND ANTIVIRAL EFFICACY OF 14 DAYS OF THE CYCOPHILIN INHIBITOR NIM811 IN COMBINATION WITH PEGYLATED INTERFERON α2a IN RELAPSED GENOTYPE 1 HCV INFECTED PATIENTS

J. Praestgaard, E. Lawitz, T. Evans, 2009 .

Quantification of Three Lidocaine Metabolites and Their Conjugates

M. Gray, D. Wyse, R. T. Coutts, 1990, Pharmaceutical Research.

Pharmacokinetics of ampicillin during parenteral nutrition.

W. Koo, Y. Tam, B. Finegan, 1990, JPEN. Journal of parenteral and enteral nutrition.